Dutasteride

What dutasteride is and who it is for

Dutasteride is a prescription capsule that shrinks an enlarged prostate. It belongs to a drug class called 5-alpha reductase inhibitors, often shortened to 5-ARIs. US labeling approves it for symptomatic benign prostatic hyperplasia (BPH), the non-cancerous prostate growth that is common with age. It is taken by mouth, usually for the long term.

The typical patient is an older man whose prostate is pressing on the urethra. That causes a weak stream, trouble starting, dribbling at the end, urgency, and repeated trips to the bathroom at night. This medicine does not fix those symptoms overnight. It works by making the gland smaller over months, so most men are told to judge results after roughly six months rather than six days.

It is prescription only in the United States, and it is sold both as a generic capsule and under the brand name Avodart. There is also a fixed combination capsule that pairs it with tamsulosin, an alpha blocker that relaxes muscle in the bladder neck. The two drugs work in different ways, which is why they are sometimes packaged together. If you are mapping out related treatments, the Full Medication Library covers the other compounds telehealth programs commonly prescribe for men’s health.

How the drug works in the body

Testosterone is converted into a stronger hormone called dihydrotestosterone, or DHT, by an enzyme named 5-alpha reductase. DHT is the hormone that drives prostate tissue to grow. In people who are genetically prone to pattern hair loss, DHT also shrinks scalp follicles until the hairs grow thinner and shorter.

The enzyme comes in more than one form. This medicine blocks both the type 1 and type 2 forms, which is the main pharmacological difference between it and finasteride. Clinical pharmacology data in the labeling describe a large drop in circulating DHT at the approved daily dose, on the order of ninety percent. Prostate volume then falls gradually, and urine flow may improve as the pressure eases. A plain-language summary of the mechanism is available through the NIH StatPearls entry on this drug.

One property matters more than most patients expect: the drug leaves the body very slowly. Its serum half-life at steady state is measured in weeks, not hours, and small amounts can still be detected in blood for months after the last capsule. That has three practical effects. Benefits fade slowly if you stop. Side effects can also take a while to settle. And men on treatment are told not to donate blood until at least six months after their final dose, so that a pregnant recipient is never exposed. Dosing details, including how the capsule should be swallowed whole rather than chewed or opened, belong to the prescriber and the official label, which you can look up through the NIH DailyMed label database.

Approved uses, and what the label does not cover

US labeling is narrow and specific. On its own, the drug is approved to treat symptomatic BPH in men with an enlarged prostate: to improve symptoms, to reduce the risk of acute urinary retention (a sudden inability to pass urine), and to reduce the risk of needing prostate surgery. Combined with tamsulosin, it is approved for symptomatic BPH in men with an enlarged prostate.

The label also states a limitation that gets misread constantly: it is not approved for the prevention of prostate cancer. Studies of prostate cancer risk exist, but the regulatory conclusion is unchanged. Nothing on this page should be read as a cancer prevention strategy.

Three other uses fall outside the US label. It is not approved for male pattern hair loss in the United States, even though it is licensed for that purpose in some other countries. It is not approved for women. It is not approved for children. Background on the underlying condition and the other treatment routes for it is available from the NIDDK page on prostate enlargement, and treatment sequencing is covered in the American Urological Association clinical guidelines.

Dutasteride versus finasteride

These two drugs are cousins, not twins. Both lower DHT. They differ in which enzyme forms they block, how long they linger, and what regulators have approved them to treat.

Because both drugs act on the same hormone pathway, their side effect profiles overlap heavily. Head-to-head comparisons of tolerability have not produced a clean verdict, and reported rates vary between trials. The longer half-life is the practical distinction: if a side effect appears, it may take longer to fade after stopping. Our separate write-up on Finasteride Uses And Risks covers the other side of that comparison in the same plain-English format.

Hair loss: what the evidence actually supports

This is the most searched use of the drug and the least settled. In the United States, prescribing it for androgenetic alopecia (pattern hair loss) is off label. Some countries, including South Korea and Japan, have licensed it for male pattern baldness. An off-label prescription is legal and common, but it means the FDA has not reviewed the drug for that purpose.

What can it do? Because it suppresses DHT more completely than the type 2 blocker, some published trials report greater gains in hair count and thickness. The evidence base is smaller and shorter than the one behind finasteride. Realistically, 5-ARIs mostly slow further loss and thicken hairs that have shrunk but are still alive. They do not revive follicles that are gone, and any benefit is maintenance: it fades if treatment stops. Timelines run in months, and shedding can briefly worsen early on. Patient-facing background on hair loss treatment expectations is published by the American Academy of Dermatology.

Topical minoxidil is frequently used alongside it. Minoxidil works on the follicle and its blood supply rather than on hormones, so the two are complementary rather than duplicative. Some telehealth programs offer compounded topical solutions that combine a 5-ARI with minoxidil; see the notes on compounding below before assuming those are equivalent to an approved product. Our guide to Topical Minoxidil Basics explains how that side of a regimen is usually structured.

Women are a separate matter. The drug is contraindicated in women, and the pregnancy risk described in the warnings section below is the reason. Any use for female pattern hair loss is off label, outside labeling, and firmly specialist territory that requires reliable contraception and a detailed conversation with a clinician who knows the case.

Side effects, from common to rare

Most men take this medicine without trouble, but the side effects that do occur cluster in one predictable place: sexual function and breast tissue. In the pivotal BPH trials, the reported problems were erectile dysfunction, reduced sex drive, and changes in ejaculation, each affecting a small percentage of participants. Labeling notes that these events were most common in the first six months and that new reports became less frequent with continued treatment.

Breast effects are less common but worth knowing about: tenderness, swelling, or enlargement of breast tissue. Any new breast lump, pain, or nipple discharge should be reported promptly rather than watched.

Semen changes have been documented too, including reduced semen volume, lower total sperm count, and reduced sperm motility. That matters if you are trying to conceive, and it is a conversation to have before starting rather than after.

Less frequent reactions include allergic responses such as rash, itching, hives, and localized swelling. Serious skin reactions and angioedema (swelling of the face, lips, tongue, or throat) have been reported and need emergency care. Reports of depressed mood and testicular pain have also been collected since the drug went to market. A general patient-level summary of adverse effects is maintained by Mayo Clinic in its oral route drug entry.

Are side effects permanent? Some men report sexual symptoms that persist after stopping a 5-ARI. The topic is genuinely contested: case reports and patient surveys exist, controlled evidence is limited, and no consensus has been reached on how often it happens or why. Two honest statements can sit together here. Persistent symptoms are reported. They have not been shown to be common. Given the long half-life, allow weeks to months before judging whether a symptom is fading.

Warnings: PSA, cancer risk and pregnancy exposure

Three warnings deserve more attention than the rest.

First, prostate-specific antigen testing. This drug cuts serum PSA by roughly half. If your urologist does not know you are taking it, a normal-looking result can hide a problem. Clinicians typically establish a new baseline after several months and interpret later readings against that. Any confirmed rise in PSA during treatment should be evaluated, even when the number still sits inside the normal range for untreated men.

Second, high-grade prostate cancer. Labeling states that this medicine may increase the risk of high-grade prostate cancer. That signal came from long-term prevention studies and is the reason the drug is not approved to prevent cancer at all. Discuss screening plans with the prescriber before starting, and see the FDA drug safety and availability hub for regulator communications on this drug class.

Third, pregnancy. The drug can be absorbed through the skin, and it can interfere with the normal development of a male fetus. Women who are pregnant or could become pregnant should not handle leaking capsules. If contact happens, the area should be washed right away. The six-month blood donation deferral after the last dose exists for the same reason. The medicine is contraindicated in women, in children, and in anyone with a known hypersensitivity to it or to other 5-ARIs.

One more precaution sits quietly in the label: other urological conditions can cause the same urinary symptoms. Infection, prostate cancer, bladder stones, strictures, an underactive bladder, and neurological disease all mimic BPH. Those need ruling out before a long-term prescription makes sense, which is exactly why a proper workup beats a fast questionnaire.

Interactions and what to disclose

The drug is broken down largely by the liver enzyme CYP3A4. Strong inhibitors of that enzyme can raise blood levels. Labeling names examples such as ritonavir, ketoconazole, verapamil, diltiazem, cimetidine, and ciprofloxacin, and advises caution when long-term use is combined with them. That is a conversation about monitoring, not an automatic ban.

Alpha blockers such as tamsulosin are frequently prescribed alongside it, sometimes in one capsule. The combination can add to dizziness and lightheadedness when standing, particularly at the start. Anyone planning cataract surgery should tell the eye surgeon about alpha blocker use, because it can affect the procedure.

Beyond formal interactions, tell your clinician about testosterone therapy, other 5-ARIs, saw palmetto or other prostate supplements, any liver disease, plans to father a child, upcoming blood donation, and upcoming PSA testing. Food does not meaningfully change absorption, so the capsule can be taken with or without a meal. Pharmacy-level interaction checks for your full medication list are available through the MedlinePlus drug information index.

What a month costs when you pay cash

Across the telehealth programs tracked on this site, the lowest self-pay price for a plan that includes this medication is $10 a month, with a tracked median of $42. All figures on this site are US dollars per month, and self-pay pricing is kept separate from what a plan or membership costs when insurance is billed. Advertised prices move often, so treat any figure as a snapshot rather than a fixture.

Several things move the number. Generic capsules are usually the cheapest route, and the brand version sits above them. A fixed combination product with tamsulosin is priced differently again. Some programs quote a bundled monthly fee that folds in the consultation, refills, and shipping; others charge a membership and bill the medication separately, so the headline figure is only part of the bill. Ninety-day fills often lower the per-month cost. Watch for introductory pricing that steps up at renewal, which is the single most common reason a first invoice and a fourth invoice do not match.

Yearly totals make those differences obvious, and they are easy to underestimate for a drug taken indefinitely.

Insurance is a separate track. Generic 5-ARIs are long established, and many plans list them, but formularies, tiers, and step requirements differ by plan and by state. Never assume; check the drug against your own formulary and ask whether a prior authorization applies. Coverage and cost policy context is published by KFF in its health costs research. If you want to see how a month-by-month comparison is laid out before you start one, the Sample Savings Report shows the format, and the Free Cost Calculators handle the arithmetic.

How telehealth programs handle this prescription

Programs that prescribe 5-ARIs online vary more than their landing pages suggest. Five things are worth comparing directly.

1. What the program actually treats. A urology-oriented service handling BPH is a different proposition from a hair loss brand prescribing off label.
2. The consult model. Some route you to a licensed clinician by video; others use asynchronous questionnaires reviewed by a prescriber. Telemedicine prescribing rules are set state by state, so what is offered in one state may not be offered in another.
3. Baseline testing and monitoring. Ask whether a PSA test is required or recommended before starting, and how follow-up is scheduled. For prostate symptoms in particular, no labs and no follow-up is a real red flag.
4. Pharmacy fulfillment. An FDA-approved generic dispensed by a licensed pharmacy is not the same product as a compounded topical solution. Compounded preparations are not FDA approved and are not reviewed for safety, efficacy, or quality before they are sold, even when the active ingredient is approved elsewhere. Background is published at the FDA human drug compounding hub.
5. Billing mechanics. Confirm what the monthly charge includes, how cancellation works, and whether messaging a clinician between refills costs extra.

To see which services list this molecule and how they compare on those dimensions, start with the Telehealth Provider Directory, and read the Scoring Methodology Explained page for what each score dimension measures. Ongoing coverage of how these programs change their pricing and clinical models sits in our Independent Editorial Coverage.

Questions to ask, and when to get help fast

Bring these to the first appointment, whether it happens in an office or on a screen:

• Have other causes of my urinary symptoms been ruled out?
• What is my PSA before I start, and how will you interpret it afterwards?
• How long before we judge whether this is working, and what happens if it is not?
• Would an alpha blocker alone, or a combination, suit my prostate size better?
• What sexual side effects should I report, and what will you do if they appear?
• Does this affect my plans to father a child?
• Who monitors me long term, and how do refills and follow-up work?

Some symptoms should not wait for a message reply. Complete inability to pass urine is acute urinary retention and needs emergency care. So does swelling of the face, lips, tongue, or throat, trouble breathing, or a blistering, peeling rash. Contact a clinician promptly for a new breast lump, breast pain, or nipple discharge, for yellowing of the eyes or skin, and for new or worsening depression or thoughts of self-harm.

Authoritative sources

• Drugs@FDA approval and labeling records
• NIH StatPearls pharmacology and adverse effects review
• Cleveland Clinic patient drug summary

Educational content, not medical advice. Always consult a qualified clinician before starting, stopping or switching treatment.